Leading national cannabis company contributes $40,000 as a portion of its proceeds from special edition Freedom Pre-Roll to Last Prisoner Project
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida today announced a donation of $40,000 to the Last Prisoner Project from its “Roll it Up for Justice” campaign. The campaign is part of Trulieve’s ongoing efforts to support initiatives aimed at bringing restorative justice to the lives of those unfairly impacted by past cannabis convictions.
The $40,000 donation to the Last Prisoner Project was raised through sales of Trulieve’s limited-edition Freedom Pre-Roll during the first two weeks of October and followed Trulieve’s recent expungement clinics held in Florida and Massachusetts in September. As part of its commitment to provide resources and opportunities to those impacted by a system of drug enforcement that disproportionately affected low-income groups and communities of color, Trulieve sponsored 125 applicants across its Florida communities to help have their records expunged or sealed. In Massachusetts , Trulieve sponsored an online clinic in connection with the CultivatED Program, supporting an additional 25 expungement candidates.
“The work being done by the Last Prisoner Project is critical to creating a more equitable and fair society,” explained Kim Rivers , CEO of Trulieve. “While we are proud to do our part to help improve and restore the lives of those unfairly impacted by marijuana convictions via expungement and clemency efforts, there is still so much more to be done. We look forward to continuing our commitment to our communities and the people most impacted by minor and victimless cannabis-related offenses and encourage others in our industry to do the same.”
Trulieve believes it is critical to give back to the communities it operates in and understands the importance of promoting cannabis reform. By working with the Last Prisoner Project, Minorities 4 Medical Marijuana, and other organizations, Trulieve supports individuals with criminal records who often experience collateral consequences that impact their lives for years after sentences have been served.
“We thank Trulieve for this generous donation as well as their continued support of the Last Prison Project and its work to address the fundamental injustice inflicted upon those who have suffered criminal cannabis convictions,” said Mary Bailey , managing director of the Last Prisoner Project. “As the United States continues to move away from the criminalization of cannabis, it is critical that operators, governments and other organizations come together to provide opportunities for those impacted by cannabis prohibition.”
To learn more about the Last Prisoner Project, please visit www.LastPrisonerProject.org
Trulieve is a vertically integrated “seed-to-sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery. Trulieve also operates in California , Massachusetts and Connecticut . Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.
To learn more about Trulieve, visit www.Trulieve.com .
SOURCE Trulieve Cannabis Corp.
News Provided by PR Newswire via QuoteMedia
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact email@example.com, or